Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

2.

Circulating inflammation markers and prospective risk for lung cancer.

Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.

3.

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

Shiels MS, Katki HA, Hildesheim A, Pfeiffer RM, Engels EA, Williams M, Kemp TJ, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2015 Jul 28;107(10). pii: djv199. doi: 10.1093/jnci/djv199. Print 2015 Oct.

PMID:
26220734
4.

Inflammatory biomarkers and risk of lung cancer.

Lagiou P, Trichopoulos D.

J Natl Cancer Inst. 2011 Jul 20;103(14):1073-5. doi: 10.1093/jnci/djr220. Epub 2011 Jun 17. No abstract available.

PMID:
21685358
5.

C-reactive protein and risk of lung cancer.

Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ, Engels EA.

J Clin Oncol. 2010 Jun 1;28(16):2719-26. doi: 10.1200/JCO.2009.27.0454. Epub 2010 Apr 26.

6.

Cigarette smoking and variations in systemic immune and inflammation markers.

Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK.

J Natl Cancer Inst. 2014 Oct 1;106(11). pii: dju294. doi: 10.1093/jnci/dju294. Print 2014 Nov.

7.

Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N.

Gynecol Oncol. 2014 Nov;135(2):297-304. doi: 10.1016/j.ygyno.2014.08.025. Epub 2014 Aug 23.

8.

Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.

Bittoni MA, Focht BC, Clinton SK, Buckworth J, Harris RE.

Int J Oncol. 2015 Oct;47(4):1537-44. doi: 10.3892/ijo.2015.3141. Epub 2015 Aug 31.

PMID:
26323323
9.

Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.

Ho GYF, Zheng SL, Cushman M, Perez-Soler R, Kim M, Xue X, Wang T, Schlecht NF, Tinker L, Rohan TE, Wassertheil-Smoller S, Wallace R, Chen C, Xu J, Yu H.

J Natl Cancer Inst. 2016 Apr 12;108(7). doi: 10.1093/jnci/djw012. Print 2016 Jul.

PMID:
27071409
10.

A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Ryan BM, Pine SR, Chaturvedi AK, Caporaso N, Harris CC.

J Thorac Oncol. 2014 Oct;9(10):1494-503. doi: 10.1097/JTO.0000000000000278.

11.

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC.

J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. doi: 10.1093/jnci/djr173. Epub 2011 May 23.

12.

Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.

de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 29;9:735-43. doi: 10.2147/COPD.S64135. eCollection 2014.

13.

Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.

Brenner DR, Fanidi A, Grankvist K, Muller DC, Brennan P, Manjer J, Byrnes G, Hodge A, Severi G, Giles GG, Johansson M, Johansson M.

Am J Epidemiol. 2017 Jan 15;185(2):86-95. doi: 10.1093/aje/kww159. Epub 2016 Dec 20.

PMID:
27998891
14.

Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):600-610. doi: 10.1002/ijc.30478. Epub 2016 Nov 7.

PMID:
27770434
15.

Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.

Grote VA, Kaaks R, Nieters A, Tjønneland A, Halkjær J, Overvad K, Skjelbo Nielsen MR, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Becker S, Pischon T, Boeing H, Trichopoulou A, Cassapa C, Stratigakou V, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Rodríguez L, Duell EJ, Sánchez MJ, Dorronsoro M, Navarro C, Gurrea AB, Siersema PD, Peeters PH, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen NE, Travis RC, Fedirko V, Jenab M, Michaud DS, Chuang SC, Romaguera D, Bueno-de-Mesquita HB, Rohrmann S.

Br J Cancer. 2012 May 22;106(11):1866-74. doi: 10.1038/bjc.2012.172. Epub 2012 Apr 26.

16.

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

Pinsky PF, Kramer BS.

J Natl Cancer Inst. 2015 Oct 19;107(11). pii: djv226. doi: 10.1093/jnci/djv226. Print 2015 Nov.

17.

Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.

Douglas JB, Silverman DT, Weinstein SJ, Graubard BI, Pollak MN, Tao Y, Virtamo J, Albanes D, Stolzenberg-Solomon RZ.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):359-69. doi: 10.1158/1055-9965.EPI-10-1024. Epub 2010 Dec 20.

18.

Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.

Bao Y, Giovannucci EL, Kraft P, Qian ZR, Wu C, Ogino S, Gaziano JM, Stampfer MJ, Ma J, Buring JE, Sesso HD, Lee IM, Rifai N, Pollak MN, Jiao L, Lessin L, Cochrane BB, Manson JE, Fuchs CS, Wolpin BM.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):855-61. doi: 10.1158/1055-9965.EPI-12-1458. Epub 2013 Mar 5.

19.

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM.

JAMA. 2002 Aug 28;288(8):980-7.

PMID:
12190368
20.

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.

Borges ÁH, Silverberg MJ, Wentworth D, Grulich AE, Fätkenheuer G, Mitsuyasu R, Tambussi G, Sabin CA, Neaton JD, Lundgren JD; INSIGHT SMART; ESPRIT; SILCAAT Study Groups.

AIDS. 2013 Jun 1;27(9):1433-41. doi: 10.1097/QAD.0b013e32835f6b0c.

Supplemental Content

Support Center